Seeking Alpha
24 Sept 2026, 06:39 UTC · 1h ago
Verdict
Headline takes no side. We score ARCT +0.60 — strongly bullish.
+0.60strongly bullish
More positive than 74% of ticker scores this week
Which stocks this story touches
More positive than 74% of ticker scores this week
The company is presenting Phase II data and highlighting advances in its mRNA liver therapeutics platform.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
1h ago
—
ARCT hasn't traded since this ran. Last close $13.30 (Sep 23); the reaction starts at the next open.
ARCT chart →
